BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND RBM15, Q96T37, 64783, ENSG00000162775, OTT, OTT1
12 results:

  • 1. Defining the operative time threshold for safety in patients undergoing robotic pancreaticoduodenectomy.
    Delman AM; Whitrock JN; Turner KM; Donovan EC; Quillin RC; Shah SA; Patel SH; Ahmad SA; Wilson GC
    HPB (Oxford); 2024 Mar; 26(3):323-332. PubMed ID: 38072726
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. rbm15‑mediating MDR1 mRNA m
    Yuan J; Guan W; Li X; Wang F; Liu H; Xu G
    Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594126
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effect of the m6ARNA gene on the prognosis of thyroid cancer, immune infiltration, and promising immunotherapy.
    Xia M; Wang S; Ye Y; Tu Y; Huang T; Gao L
    Front Immunol; 2022; 13():995645. PubMed ID: 36389678
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma.
    Zhang T; Sheng P; Jiang Y
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):2805-2822. PubMed ID: 35780396
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA.
    Wang Y; Chen Z
    Bioengineered; 2022 Jan; 13(1):178-189. PubMed ID: 34951345
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
    Fu Y; Sun S; Bi J; Kong C; Yin L
    Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Novel Recurrent Altered Genes in Chinese Patients With Anaplastic Thyroid cancer.
    Zhang L; Ren Z; Su Z; Liu Y; Yang T; Cao M; Jiang Y; Tang Y; Chen H; Zhang W; Gong R; Wei T; Peng Y; Liu B; Zhang W; Yang L; Hu Y; Li Z; Zhu J; Xu H; Shu Y; Luo H
    J Clin Endocrinol Metab; 2021 Mar; 106(4):988-998. PubMed ID: 33428730
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinicopathological and immunological characterization of RNA m
    Wang Q; Zhang Q; Li Q; Zhang J; Zhang J
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1547. PubMed ID: 33225598
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. m
    Hou J; Shan H; Zhang Y; Fan Y; Wu B
    Am J Otolaryngol; 2020; 41(4):102547. PubMed ID: 32474328
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Propensity Score-matched Comparison Study of Surgical Outcomes in Patients with Differentiated Thyroid cancer After Robotic Versus Open Total Thyroidectomy.
    Bae DS; Koo DH
    World J Surg; 2019 Feb; 43(2):540-551. PubMed ID: 30242457
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long-term oncologic outcome of robotic versus open total thyroidectomy in PTC: a case-matched retrospective study.
    Lee SG; Lee J; Kim MJ; Choi JB; Kim TH; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jo YS; Chung WY
    Surg Endosc; 2016 Aug; 30(8):3474-9. PubMed ID: 26514137
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.